Chronic cough, defined as a cough lasting more than eight weeks, presents a prevalent yet complex issue in clinical practice. Despite its seeming simplicity, its multifaceted nature poses a challenge to healthcare professionals. This article seeks to shed light on this often mystifying condition and provide a comprehensive approach to its management.
Chronic cough can be attributed to a plethora of causes, including but not limited to postnasal drip syndrome, gastroesophageal reflux disease (GERD), and asthma. It is crucial to conduct a thorough patient history and physical examination to identify potential causes. Additional diagnostic tests may be necessary to confirm the diagnosis.
Treatment should be individualized based on the identified cause. For instance, GERD-related coughs may require proton pump inhibitors, while coughs due to asthma might need inhaled corticosteroids. It is essential to monitor patients closely and adjust the treatment plan as necessary.
Refractory chronic cough, or cough that remains unresponsive to treatment, requires further evaluation. This could include high-resolution computed tomography, bronchoscopy, or referral to a specialist. Neuromodulatory therapies can be considered in cases of refractory chronic cough.
Patients must understand their condition and the importance of adhering to the treatment plan. Educating patients about potential triggers and how to avoid them can also be beneficial. Regular follow-up appointments should be scheduled to monitor progress and make necessary adjustments to the treatment plan.
Chronic cough, while common, is a complex condition that requires a comprehensive and individualized approach. By understanding the underlying causes, implementing tailored treatment plans, addressing refractory cases, and emphasizing patient education, healthcare professionals can effectively manage chronic cough in clinical practice.
1.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
What Comes After Cancer?
4.
FDA Expands Durvalumab Label to Operable Lung Cancer
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Finding Support: Connecting with the Vitiligo Community
2.
Essential Updates in Hematology in Daily Practice
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Living Better With Advanced Cancer Through Supportive Care
5.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation